| Metabolic Diseases |
NCT01865214: Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure. |
|
|
| Recruiting | 4 | 100 | RoW | Tolvaptan | Korea Otsuka International Asia Arab, Korea Otsuka Pharmaceutical Co.,Ltd. | Heart Failure With Hyponatremia | 07/14 | 12/14 | | |
NCT00948493: Treatment Use of Generex Oral-lyn™ in Patients With Diabetes |
|
|
| No Longer Available | N/A | | US | Buccal insulin spray, Generex Oral-lynTM (oral, buccal insulin spray) | Generex Biotechnology Corp. | Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | | | | |
NCT02300753: Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON] |
|
|
| No Longer Available | N/A | | US | EPI-743, Vincerinone (TM), Vatiquinone | Edison Pharmaceuticals Inc | Leber's Hereditary Optic Neuropathy | | | | |
NCT01798914: Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder |
|
|
| No Longer Available | N/A | | US | Technosphere Insulin Inhalation Powder, Afrezza Inhalation Powder | Mannkind Corporation | Type 1 Diabetes, Type 2 Diabetes | 04/15 | 05/15 | | |
NCT02097251: An Open-Label Treatment Protocol With UX003 rhGUS Enzyme Replacement Therapy for an Advanced Stage MPS 7 Patient |
|
|
| No Longer Available | N/A | | US | UX003, recombinant human beta glucuronidase, rhGUS | Joyce Fox, Ultragenyx Pharmaceutical Inc | Mucopolysaccharidosis Type 7 | | | | |
NCT00962260: Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease |
|
|
| No Longer Available | N/A | | US, RoW | Plant cell expressed recombinant glucocerebrosidase (prGCD), taliglucerase alfa | Pfizer | Gaucher Disease | | | | |